Back to Search
Start Over
Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes
- Source :
- Diabetes
- Publication Year :
- 2011
-
Abstract
- OBJECTIVE Two novel mutations (E1506D, E1506G) in the nucleotide-binding domain 2 (NBD2) of the ATP-sensitive K+ channel (KATP channel) sulfonylurea receptor 1 (SUR1) subunit were detected heterozygously in patients with neonatal diabetes. A mutation at the same residue (E1506K) was previously shown to cause congenital hyperinsulinemia. We sought to understand why mutations at the same residue can cause either neonatal diabetes or hyperinsulinemia. RESEARCH DESIGN AND METHODS Neonatal diabetic patients were sequenced for mutations in ABCC8 (SUR1) and KCNJ11 (Kir6.2). Wild-type and mutant KATP channels were expressed in Xenopus laevis oocytes and studied with electrophysiological methods. RESULTS Oocytes expressing neonatal diabetes mutant channels had larger resting whole-cell KATP currents than wild-type, consistent with the patients’ diabetes. Conversely, no E1506K currents were recorded at rest or after metabolic inhibition, as expected for a mutation causing hyperinsulinemia. KATP channels are activated by Mg-nucleotides (via SUR1) and blocked by ATP (via Kir6.2). All mutations decreased channel activation by MgADP but had little effect on MgATP activation, as assessed using an ATP-insensitive Kir6.2 subunit. Importantly, using wild-type Kir6.2, a 30-s preconditioning exposure to physiological MgATP concentrations (>300 µmol/L) caused a marked reduction in the ATP sensitivity of neonatal diabetic channels, a small decrease in that of wild-type channels, and no change for E1506K channels. This difference in MgATP inhibition may explain the difference in resting whole-cell currents found for the neonatal diabetes and hyperinsulinemia mutations. CONCLUSIONS Mutations in the same residue can cause either hyperinsulinemia or neonatal diabetes. Differentially altered nucleotide regulation by NBD2 of SUR1 can explain the respective clinical phenotypes.
- Subjects :
- Male
medicine.medical_specialty
endocrine system
Receptors, Drug
Endocrinology, Diabetes and Metabolism
Glutamic Acid
Sulfonylurea Receptors
medicine.disease_cause
ABCC8
Xenopus laevis
03 medical and health sciences
Diabetes mellitus genetics
0302 clinical medicine
KATP Channels
Hyperinsulinism
Internal medicine
Diabetes Mellitus
Genetics
Internal Medicine
Diazoxide
medicine
Hyperinsulinemia
Animals
Humans
Potassium Channels, Inwardly Rectifying
030304 developmental biology
0303 health sciences
Mutation
biology
Genetics (medical sciences)
Diabetes
Infant, Newborn
Kir6.2
medicine.disease
Potassium channel
Protein Structure, Tertiary
Rats
Electrophysiology
Endocrinology
Mutagenesis, Site-Directed
biology.protein
Sulfonylurea receptor
ATP-Binding Cassette Transporters
030217 neurology & neurosurgery
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 1939327X and 00121797
- Volume :
- 60
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Diabetes
- Accession number :
- edsair.doi.dedup.....9942b48698d38a33303e1ef05683cf06